So with great data from the MPL phase 1 or was it a phase 1/ 2...

So with great data from the MPL phase 1 or was it a phase 1/ 2 who knows, what has gone wrong.
First with great data and submitting of ODD application along with so called great direction from FDA and big talking by MT he could not get sufficient option holders to convert their options which would have given PAA cash in hand.
MT couldn't get shareholders to not sell downwards
MT wasn't able to any one interested in doing a license deal for MND , canine or for a full take over
Delay in ODD decision due to no data being submitted with the first application
FDA taking their time to give a decision on ODD
Lack of cash on hand, imo they expected a lot of options to be converted.
Additional wage bill
The mnd phase 2/3 trial still not commenced and conflicting information in announcements over the anticipated start date.


So now we look forward to
Quarterly
ODD decision
Start of mnd trial
How funding will be obtained
Up date on extension trial and hopefully all patients still doing well